, , 2012.
, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity, vol.37, pp.158-170
Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host Microbe, vol.23, pp.716-724, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01821219
, , 2019.
, Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response, Nat. Commun, vol.10, pp.3273-3289
Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis, PLoS ONE, vol.13, 2018. ,
Regulation of inflammation by microbiota interactions with the host, Nat. Immunol, vol.18, pp.851-860, 2017. ,
Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection, Cell Rep, vol.28, pp.245-256, 2019. ,
Labs rush to study coronavirus in transgenic animalssome are in short supply, Nature, vol.579, p.183, 2020. ,
COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review, Clin. Pract, vol.10, pp.1271-1277, 2020. ,
Clinical and immunological features of severe and moderate coronavirus disease 2019, J. Clin. Invest, vol.130, pp.2620-2629, 2020. ,
Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis, Gastroenterology, 2020. ,
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral Res, vol.176, pp.104742-104746, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02890592
, , 2002.
, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, vol.417, pp.822-828
Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons, PLoS Pathog, vol.12, p.1005572, 2016. ,
Faecal calprotectin indicates intestinal inflammation in COVID-19, Gut, 2020. ,
Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus, Annu. Rev. Med, vol.68, pp.387-399, 2017. ,
Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2, Circ. Res, vol.126, pp.1456-1474, 2020. ,
Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota, Front. Immunol, vol.9, pp.182-193, 2018. ,
Alterations of the gut microbiota in patients with COVID-19 or H1N1 Influenza, Clin. Infect. Dis, 2020. ,
Clinical characteristics of Coronavirus Disease 2019 in China, China Medical Treatment Expert Group for Covid, vol.382, pp.1708-1720, 2020. ,
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J. Pathol, vol.203, pp.631-637, 2004. ,
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation, Nature, vol.487, pp.477-481, 2012. ,
Neurologic features in Severe SARS-CoV-2 infection, N. Engl. J. Med, vol.382, pp.2268-2270, 2020. ,
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, vol.181, pp.271-280, 2020. ,
Impact of obesity on Influenza A Virus pathogenesis, immune response, and evolution, Front. Immunol, vol.10, pp.1071-1084, 2019. ,
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, vol.395, pp.497-506, 2020. ,
Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc. Natl. Acad. Sci. USA, vol.108, pp.5354-5359, 2011. ,
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, vol.69, pp.1002-1009, 2020. ,
Altered gut microbiome profile in patients with pulmonary arterial hypertension, Hypertension, vol.75, pp.1063-1071, 2020. ,
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med, vol.11, pp.875-879, 2005. ,
,
, SARS-CoV-2 productively infects human gut enterocytes, 2020.
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease, Nat. Rev. Gastroenterol. Hepatol, vol.17, pp.223-237, 2020. ,
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus, Gut, vol.69, pp.1141-1143, 2020. ,
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, vol.69, pp.997-1001, 2020. ,
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J, vol.39, 2020. ,
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis, Lancet Gastroenterol. Hepatol, vol.5, pp.667-678, 2020. ,
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J. Virol, vol.84, pp.12658-12664, 2010. ,
The co-pathogenesis of influenza viruses with bacteria in the lung, Nat. Rev. Microbiol, vol.12, pp.252-262, 2014. ,
Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States, Gastroenterology, 2020. ,
Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-Sectional, multicenter study, Am. J. Gastroenterol, vol.115, pp.766-773, 2020. ,
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), J. Med. Virol, vol.92, pp.699-702, 2020. ,
Influence of H7N9 virus infection and associated treatment on human gut microbiota, Sci. Rep, vol.5, pp.14771-14784, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02638858
The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases, J. Cell. Physiol, vol.234, pp.2277-2295, 2019. ,
Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2 infection in the United States: A multicenter cohort study, Gastroenterology, 2020. ,
Brain-gutbone marrow axis: Implications for hypertension and related therapeutics, Circ. Res, vol.118, pp.1327-1336, 2016. ,
Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production, Cell Rep, vol.30, pp.2934-2947, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-02501395
Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations, Diabetes Metab. Syndr, vol.14, pp.303-310, 2020. ,
Oxygen battle in the gut: hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine, J. Biol. Chem, 2020. ,
The microbial metabolite desaminotyrosine protects from influenza through type I interferon, Science, vol.357, pp.498-502, 2017. ,
AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19, 2020. ,
A mouse model of SARS-CoV-2 infection and pathogenesis, Cell Host Microbe, 2020. ,
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, HCA Lung Biological Network, vol.26, pp.681-687, 2020. ,
Dietary fiber confers protection against flu by shaping Ly6c À patrolling monocyte hematopoiesis and CD8 + T cell metabolism, Immunity, vol.48, pp.992-1005, 2018. ,
Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J. Exp. Med, vol.211, pp.2397-2410, 2014. ,
A novel coronavirus outbreak of global health concern, Lancet, vol.395, pp.470-473, 2020. ,
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2, Cell, vol.181, pp.894-904, 2020. ,
, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in, vol.323, pp.1061-1069, 2020.
Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, 2020. ,
Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, vol.158, pp.1831-1833, 2020. ,
Infectious SARS-CoV-2 in feces of patient, 2020. ,
, Infect. Dis, vol.26, 2020.
Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis, vol.6, pp.9-25, 2018. ,
Immunodepletion with hypoxemia: A potential high risk subtype of coronavirus disease, 2019. ,
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes, Sci. Immunol, vol.5, p.3582, 2020. ,
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerg. Microbes Infect, vol.9, pp.386-389, 2020. ,
Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov, 2020. ,
A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, pp.270-273, 2020. ,
Effect of gastrointestinal symptoms in patients with COVID-19, Gastroenterology, vol.158, pp.2294-2297, 2020. ,
Infection of bat and human intestinal organoids by SARS-CoV-2, Nat. Med, p.13, 2020. ,
A Novel Coronavirus from Patients with Pneumonia in China, China Novel Coronavirus Investigating and Research Team, vol.382, pp.727-733, 2019. ,
Alterations in gut microbiota of patients with COVID-19 during time of hospitalization, Gastroenterology, 2020. ,